'Videoconferencing Dysmorphia' Drives Interest in Cosmetic Procedures
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 7, 2025 -- Videoconferencing and the application of filters are significantly associated with a heightened interest in cosmetic procedures, according to a study published online Jan. 6 in the Journal of Clinical and Aesthetic Dermatology.
Payal M. Patel, M.D., from Massachusetts General Hospital in Boston, and colleagues examined the association between the increased use of videoconferencing and image-enhancing software filters during the COVID-19 pandemic and the corresponding rise in interest in cosmetic procedures. The analysis included survey results from 505 U.S. adults.
The researchers found that videoconferencing was frequent, with 88.6 percent using it more than three days a week; 68.1 percent reported using "touch-up my appearance" filters more than half the time. The desire for cosmetic procedures was influenced by videoconferencing in 55.9 percent of participants, while 57.8 percent were influenced by filter use. Two-thirds of respondents reported frequent self-viewing, which was strongly associated with interest in cosmetic procedures. Filter use was significantly predicted by higher income (odds ratio, 2.436) and frequent self-viewing behavior (odds ratio, 5.034). In frequent self-viewers, mask wearing was associated with increased self-esteem (68.8 percent) and a reduced desire for cosmetic procedures (67.4 percent).
"These insights are vital for dermatologists in understanding patient motivations, managing expectations, and fostering realistic treatment outcomes," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-09 00:00
Read more
- Too Much Screen Time Harms Preschoolers' Sleep, Behavior
- Act Fast and You Can Still Enroll In An ACA Healthcare Plan for 2025
- Study: Blood Transfusion Post-Heart Attack May Be Critical for Those with Anemia
- Use Your Freezer to Fight Food Waste, Protect the Planet
- ACIP Updates Recommendations for Bexsero MenB-4C Vaccine
- Celiac Disease Linked to Higher Risk for Developing Alopecia Areata
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions